血清肌酐/胱抑素C比值诊断低MRI肌肉体积和低握力的效能:英国生物银行老年人数据
研究基于英国生物银行老年人数据,评估血清肌酐/胱抑素C比值识别低MRI大腿无脂肌肉体积和低握力的诊断效能。在调整混杂因素后,该比值对低肌肉体积的AUC为0.577-0.722,对低握力AUC均<0.70,提示诊断效能差至可接受。结论认为该比值可能不适合作为识别老年人低肌肉体积或低力量的生物标志物。
要点
- 肌酐/胱抑素C比值与低肌肉体积和低握力显著相关,但诊断效能有限。
- 识别低大腿无脂肌肉体积的AUC在男性为0.577-0.609,女性为0.622-0.722。
- 识别低握力的AUC均<0.70,无论采用何种切点。
核心结论
- 肌酐/胱抑素C比值可能不适合作为识别老年人低肌肉体积或低力量的生物标志物。
- 尽管关联显著,但诊断效能差至可接受,不足以用于临床筛查。
研究设计与样本
- 基于英国生物银行老年人的大型观察性研究,基线2008-2010年测量血清肌酐、胱抑素C和握力,影像访视2014-2018年测量MRI大腿无脂肌肉体积和DXA四肢瘦体重。
主要发现
- 在完全调整模型中,肌酐/胱抑素C比值识别低大腿无脂肌肉体积(第20百分位切点)的AUC男性0.577、女性0.622。
- 识别低大腿无脂肌肉体积(T评分-2切点)的AUC男性0.596、女性0.659;T评分-2.5切点AUC男性0.609、女性0.722。
- 识别低四肢瘦体重/体重指数或低握力的AUC均<0.70,无论采用何种切点。
关键数值与推荐
- 低大腿无脂肌肉体积定义采用第20百分位切点及T评分-2和-2.5切点。
- 低四肢瘦体重/体重指数和低握力采用不同切点评估,但原文未报告具体数值。
临床怎么用
- 不建议将血清肌酐/胱抑素C比值单独用于老年肌少症筛查或低肌肉量/低握力的诊断。
- 临床识别肌少症仍需结合影像学肌肉体积和握力等功能评估。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Biomarkers for sarcopenia are lacking. We examined the diagnostic power of serum creatinine to cystatin C ratio for identifying low magnetic resonance imaging-muscle volume and low grip strength in a large observational study of UK Biobank older adults. METHODS: Serum creatinine and cystatin C were measured via immunoassays (Beckman Coulter AU5800 and Siemens Advia 1800, respectively) and grip strength by hydraulic hand dynamometer at baseline visit (2008-2010). magnetic resonance imaging-thigh fat-free muscle volume and DXA-derived appendicular lean mass were measured at imaging visit (2014-2018). Extreme outliers were removed, and covariates (demographic, lifestyle, and clinical factors, as well as time elapsed between baseline-imaging visit) were adjusted for in statistical models. RESULTS: 12 873 older adults (mean age: 63.5 ± 2.7 years, 44.2% women) were included for fat-free muscle volume and appendicular lean mass/body mass index; 149 707 older adults (mean age: 64.0 ± 2.9 years, 50.5% women) for grip strength. Despite significant associations (p < .05), in fully adjusted models, creatinine to cystatin C showed poor to acceptable diagnostic power for identifying low fat-free muscle volume when using cutpoints of 20th percentile (area under the curve: 0.577 men; 0.622 women) and T scores of -2 (area under the curve: 0.596 men; 0.659 women) and -2.5 (area under the curve: 0.609 men; 0.722 women). In fully adjusted model, creatinine to cystatin C showed poor diagnostic power (area under the curves: <0.70) for identifying low appendicular lean mass/body mass index or low grip strength, irrespective of the cutpoint used. CONCLUSIONS: Creatinine to cystatin C may not be a suitable biomarker for identifying low muscle volume or low strength in older adults. This finding, drawn from a large sample size and the use of advanced medical imaging, marks an important contribution to the sarcopenia field.
引用
- Kirk B, Kuo CL, Liu P, et al. Diagnostic Power of Serum Creatinine/Cystatin C Ratio for Identifying Low MRI-Muscle Volume and Low Grip Strength: Data From 9 731 to 149 707 UK Biobank Older Adults. J Gerontol A Biol Sci Med Sci. 2024. PMID: 39538979. doi:10.1093/gerona/glae274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。